August 6, 2010
Track this case
District Of Columbia
Other Statutory Actions
Rosemary M. Collyer
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A Washington federal judge on Monday threw out a suit against the U.S. Food and Drug Administration challenging its regulation of a stem cell treatment, finding the procedure constitutes a drug and is subject to FDA enforcement.
Already a subscriber? Click here to login